Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: an update of Brazilian Society of Rheumatology (2020).Archives of osteoporosis · 2021
   Pooled it
2. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.Annals of the rheumatic diseases · 2007
   Guideline
3. Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
   Trial
4. Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2009
   Trial
5. Glucocorticoid-induced osteoporosis: 2019 concise clinical review.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019
   Review
6. Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis.Osteoporosis and sarcopenia · 2016
   Review
7. Glucocorticoid-induced osteoporosis: who to treat with what agent?Nature reviews. Rheumatology · 2015
   Review
8. Osteoimmunology and osteoporosis.Arthritis research & therapy · 2011
   Review
9. Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2010
   Article
10. Bone health in a tertiary-care gastroenterology and hepatology population.Digestive diseases and sciences · 2010
    Article
11. Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options.Drug, healthcare and patient safety · 2010
    Article
12. Glucocorticoid-induced osteoporosis in rheumatic diseases.Clinics (Sao Paulo, Brazil) · 2010
    Review
13. Prevention and treatment of glucocorticoid-induced osteoporosis.Current osteoporosis reports · 2007
    Article
14. Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures.Clinical rheumatology · 2007
    Review
15. Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2006
    Review

Corrections and comments

• Comment on
  Clinical decision rules in rheumatoid arthritis: do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis Register.2002

Authors and funding

7 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as